Raymund Breu - Swiss Re Director

SSREF Stock  USD 107.39  0.61  0.56%   

Director

Dr. Raymund Breu Ph.D. was NonExecutive Independent Member of the Board of Directors at Swiss Re AG since December 2003. Additionally he was Member of Audit Committee as well as Investment Committee of the Company. He graduated from Eidgenoessische Technische Hochschule Zuerich with a Doctorate in Mathematics. Dr. Breu was Chief Financial Officer of the Novartis Group and Member of that company Executive Committee. He joined the group treasury of Sandoz a predecessor company of Novartis in 1975. 10 years later Dr. Breu was appointed Chief Financial Officer of Sandoz Corporation in New York. In 1990 he became Group Treasurer of Sandoz Ltd and in 1993 Head of Group Finance and Member of the Sandoz Executive Board. Dr. Breu serves on the Swiss Takeover Board and as Member of the Board of Directors of Nobel Biocare Holding AG. since 2003.
Age 69
Tenure 21 years
Phone41 43 285 2121
Webhttps://www.swissre.com

Swiss Re Management Efficiency

Swiss Re's management efficiency ratios could be used to measure how well Swiss Re manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 10.88 B in total debt with debt to equity ratio (D/E) of 0.86, which is about average as compared to similar companies. Swiss Re AG has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Swiss Re until it has trouble settling it off, either with new capital or with free cash flow. So, Swiss Re's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Swiss Re AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Swiss to invest in growth at high rates of return. When we think about Swiss Re's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Michele AronvaldSCOR PK
57
Todd InslerUnited Airlines Holdings
49
Pablo MercadoComfort Systems USA
43
Peter BrabeckLetmatheExxon Mobil Corp
71
Guillaume SarkozySCOR PK
64
Thomas RabautAllison Transmission Holdings
72
Kenneth FrazierExxon Mobil Corp
66
Peter EckertSCOR PK
70
Michael BoskinExxon Mobil Corp
71
Edward ShapiroUnited Airlines Holdings
53
Michele HooperUnited Airlines Holdings
66
Gregory SpivyAllison Transmission Holdings
46
Douglas OberhelmanExxon Mobil Corp
67
Alvaro GarciaTunonAllison Transmission Holdings
68
Henry MeyerUnited Airlines Holdings
64
William SandbrookComfort Systems USA
62
Herman BullsComfort Systems USA
64
Raymond NeffMaiden Holdings
75
James SchultzComfort Systems USA
71
Barney HarfordUnited Airlines Holdings
43
David DenisonAllison Transmission Holdings
62
Swiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland. Swiss Re is traded on OTC Exchange in the United States. Swiss Re AG [SSREF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Swiss Re AG Leadership Team

Elected by the shareholders, the Swiss Re's board of directors comprises two types of representatives: Swiss Re inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Swiss. The board's role is to monitor Swiss Re's management team and ensure that shareholders' interests are well served. Swiss Re's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Swiss Re's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mathis Cabiallavetta, Non-Executive Independent Vice Chairman of the Board of Directors
Trevor Manuel, Non-Executive Independent Member of the Board of Directors
Mark Senkevics, Australia Asia
Susan Wagner, Non-Executive Independent Director
Raymond Chien, Non-Executive Independent Member of the Board of Directors
Youngran Kim, Group Officer
Guido Furer, Group Switzerland
Jason Richards, Member of the Executive Board, Head Property & Casualty Business Management
C Henrikson, Non-Executive Independent Member of the Board of Directors
Matthias Weber, Member of the Executive Board, Group Chief Underwriting Officer
Raymund Breu, Non-Executive Independent Member of the Board of Directors
Mary Francis, Non-Executive Independent Member of the Board of Directors
Guido Fuerer, Member of the Executive Board, Chief Investment Officer
Paul Tucker, Non-Executive Independent Member of the Board of Directors
Eric Smith, Member of the Executive Board, CEO Swiss Re Americas, Regional President Americas
Martyn Parker, Member of the Executive Board, Chairman Global Partnerships
Patrick Raaflaub, Group Chief Risk Officer and Member of Group Management Board
Thomas Bohun, Head Relations
Hans Maerki, Non-Executive Independent Member of the Board of Directors
John Dacey, Chief Strategy Officer, Member of the Executive Board
Edouard Schmid, Member of the Executive Board, Head Property & Specialty Reinsurance
Justin Excell, Member of the Executive Board, Global Head of Rates, Asset Management
Rudolf Flunger, Member of the Executive Board, Head of Regions & Specialty Corporate Solutions
Hermann Geiger, Group Chief Legal Officer
Thierry Leger, Member of the Executive Board, Head Globals
Michel Lies, CEO, Member of the Executive Board
Agostino Galvagni, Member of the Executive Board, CEO Corporate Solutions
Philip Ryan, Non-Executive Independent Member of the Board of Directors
Philippe Brahin, Head Investor Relations
JeanJacques Henchoz, Member of the Executive Board, CEO Reinsurance EMEA, Regional President EMEA
Thomas Wellauer, Member of the Executive Board, COO
Renato Fassbind, Non-Executive Independent Member of the Board of Directors
Alison Martin, Member of the Executive Board, Head Life & Health Reinsurance
Robert Dacey, Group CFO, Member of the Executive Board
Bob Ratcliffe, Member of the Executive Board, CEO of Admin Re
Jeff Summerville, Head Casualty - Financial and Professional Services North America
Christian Mumenthaler, Member of the Executive Board, CEO Reinsurance
Cathy Desquesses, Group Services
Beat Strebel, Head business
Rajna Brandon, Non-Executive Independent Member of the Board of Directors
JeanPierre Roth, Non-Executive Independent Member of the Board of Directors
David Cole, Group CFO
Serge Troeber, Member of the Executive Board, Chief Underwriting Officer Corporate Solutions
Walter Kielholz, Non-Executive Independent Chairman of the Board of Directors
Elena Logutenkova, Head Reporting
BA MPP, Group Officer
Moses Ojeisekhoba, Member of the Executive Board, CEO Reinsurance Asia, Regional President Asia
Carlos Represas, Non-Executive Independent Member of the Board of Directors
Russell Higginbotham, CEO, Reinsurance Asia and Regional President Member of the Executive Board
Jonathan Isherwood, Head of Claims, Accounting and Liability Management Reinsurance
Markus Schmid, Member of the Executive Board, Head of Information Technology
Jayne Plunkett, Member of the Executive Board, Head Casualty Reinsurance

Swiss Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Swiss Re a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Swiss Re AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Swiss Re AG information on this page should be used as a complementary analysis to other Swiss Re's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Swiss Pink Sheet analysis

When running Swiss Re's price analysis, check to measure Swiss Re's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swiss Re is operating at the current time. Most of Swiss Re's value examination focuses on studying past and present price action to predict the probability of Swiss Re's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swiss Re's price. Additionally, you may evaluate how the addition of Swiss Re to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Please note, there is a significant difference between Swiss Re's value and its price as these two are different measures arrived at by different means. Investors typically determine if Swiss Re is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Swiss Re's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.